跳至主要内容
临床试验/NCT00741026
NCT00741026已完成不适用

A Double-blind, Placebo-controlled, Crossover Study Examining the Acute Effects of Olanzapine on Plasma Leptin, Glucose Tolerance and Free Fatty Acids in Healthy Volunteers

Milton S. Hershey Medical Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2008年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Plasma Free Fatty Acid

研究概览

简要总结

The purpose of this clinical research study is to examine the acute hormonal and metabolic effects of the drug olanzapine, as well as appetite effects, in healthy volunteers. The hypotheses to be tested are that: (1) Olanzapine rapidly attenuates plasma leptin and (2) rapidly alters glucose tolerance in healthy volunteers. These questions will be answered by having volunteers undergo two glucose tolerance tests in a crossover study design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Volunteer
  • Body Mass Index of 18.5-25 kilograms per square meter
  • Must be able to swallow tablets
  • Able to give informed consent

排除标准

  • Any DSM-IV TR Axis I psychiatric disorder (except nicotine dependence)
  • Presence of any medical disorder that may confound the assessment of relevant biologic measures, including: significant organ system dysfunction, metabolic diseases, type 1 diabetes mellitus, type 2 diabetes mellitus, pregnancy, endocrine disease, coagulopathy, clinically significant anemia, or acute infection
  • Subjects who have taken any antipsychotic medication within the last 6 months
  • Personal or family history of seizures and/or cardiac arrhythmias

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

Olanzapine

Experimental

Olanzapine 10mg po daily x 3 days

干预措施: Olanzapine 10 mg po qhs for 3 days (Drug)

结局指标

主要结局

Plasma Free Fatty Acid

时间窗: 3 Days

Plasma Free Fatty Acid

Oral Glucose Tolerance

时间窗: 3 Days

Oral Glucose Tolerance

Plasma Leptin

时间窗: 3 Days

Leptin following placebo or olanzapine treatment

次要结局

  • LDL Cholesterol(3 Days)
  • BMI(3 Days)
  • Diastolic Blood Pressure(3 Days)
  • Triglycerides(3 Days)
  • HDL Cholesterol(3 Days)
  • Systolic Blood Pressure(3 Days)
  • Total Cholesterol(3 Days)
  • Body Weight(3 Days)
  • Heart Rate(3 Days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vance L. Albaugh

MD/PhD Student

Penn State University

研究点 (1)

Loading locations...

相似试验